1Meltzer EO, Lockey RE, Friedman BF, et al. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma. Mayo Clin Proc,2002,77(5) :437.
2Staresinic AG, Sorkness CA. Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma. Expert Opin Pharmacother,2000,1(6) : 1227.
3Barnes NC, Hallett C, Harris TA. Clinical experience with fluticasone propionate in asthma : a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less. Respir Med, 1998,92(1) :95.
4Direkwattanachai C, Limkittikul K, Kraisarin C, et al. Fluticasone propionate and bronchial hyperresponsiveness in childhood asthma.Asian Pac J Allergy Immunol, 1999,17(2) :63.
5Heinig JH, Boulet LP, Croonenborghs L, et al. The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma. Respir Med,1999,93(9) :613.
6Visser MJ, Postma DS, Arends LR, et al. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma:effects on hyperresponsiveness, lung function, and height.Am J Respir Crit Care Med,2001,164(11):2073.
7Li JT, Ford LB, Chervinsky P, et al. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. J Allergy Clin Immunol, 1999,103(6) : 1062.
